+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 22Years +
All Genders
ID06956209

Evaluating Safety and Effects of the Akyva Implantable Device for Underactive Bladder Symptoms

Led by Iota Biosciences, Inc · Updated on 2026-09-14

15

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the safety and potential side effects of the Akyva System, an implantable device designed to electrically stimulate the bladder muscle to improve urination in people with underactive bladder. The study includes both patients with non-neurogenic underactive bladder and those with neurogenic underactive bladder due to spinal cord injury. Researchers want to see if the device helps reduce the need for catheter use and improves urine emptying. Participants will receive the Akyva System device implanted to directly stimulate the bladder wall muscle that controls urination. The study includes patients who currently use intermittent catheterization for urinary retention and are medically able to undergo surgery. The devices safety and surgical feasibility will be assessed from enrollment through up to 18 months after implantation. During the study, participants will be monitored for safety and any side effects following device implantation. Researchers will evaluate how well the device improves bladder emptying over 18 months, including reviewing bladder diary records and clinical assessments. Participants will undergo follow-up visits to track the devices performance and their urinary function throughout the study period, which lasts until September 2028.

CONDITIONS

Brief Title

Akyva First In Human

Research Team

A

Akyva Study Team

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here